Market closed·Syncing…
Market closed · Close · 19 Nov

JHS Svendgaard Laboratories Limited JHSshare price and chart

JHS Svendgaard Laboratories closed at ₹8.00 on 19 November 2026, down 1.23% on the day. The 52-week range is ₹6.26 to ₹13.69.

₹8.00The price one share last traded at, in rupees.▼ 1.23% · ₹0.10
52-wk low ₹623% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹14

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on JHS

Real prices, every charge counted. Pick one or write your own.

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
42.7Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
53.9%Near average
today 53.9%20d avg 68.3%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.▼ 8.5%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.▼ 7.0%1 monthHow much the share price has changed over the period.▼ 14.1%3 monthsHow much the share price has changed over the period.▼ 4.9%1 yearHow much the share price has changed over the period.▼ 31.1%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.42.1%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹70 Cr19 NovReturn on equityHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.-1.1%full year FY26Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.0.40xbooks of Sept 2026Return on capitalHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.-0.8%full year FY26EV / EBITDAWhat it would cost to buy the whole company, against the cash profit its business makes in a year. It is a P/E that ignores how the company is financed.13.2xDividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.08xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.-15.2%year to Mar 2026

Against its sectorWhere this company ranks among similar companies on each measure.

Personal Care · 13 peers · medians
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.-1.09%vs 18.05% median
Lowest: JHS -1.09%Highest: ANONDITA 41.62%
Revenue growthHow much sales grew in the latest quarter against the same quarter a year earlier.-2.01%vs 25.47% median
Lowest: JHS -2.01%Highest: CUPID 122.46%

What the numbers sayShort plain statements about this company's latest figures.

Written by fixed rules

Latest quarterIn the quarter to September 2026 (results filed 2 Nov 2026), sales fell 2.0% from a year earlier to ₹21.8 cr and profit turned positive at ₹0.5 cr after a loss of ₹0.2 cr a year earlier.

Going well
  • Operating margin rose from -8.9% in FY23 to 0.8% in FY26.
  • No promoter shares were pledged at the end of September 2026.
Worth watching
  • Reported a loss in FY24 and FY25 and FY26.
  • Profit before interest covered interest -1.6 times in FY26 (₹1 cr of interest).
  • Return on equity stayed under 10% from FY24 to FY26 (highest -1.1%).

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Share price reaction to resultsWhat the share price did around each recent quarterly result.

Over the last 18 results, the share rose on 11 and fell on 7, and moved by 3% or more on 8.

+11%
-11%
Q4 FY22Q4 FY23Q4 FY24Q4 FY25Q2 FY27

Q2 FY27: results filed 2 Nov 2026. The share went from its close on 30 Oct 2026 to its close on 3 Nov 2026 +0.13%.

What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.

Price only, before dividends
-13.9%a year, over 10 years
1 yr
-30.2%
3 yr
-33.0%
5 yr
-19.0%
10 yr
-13.9%

Held for 10 years this compounded at -13.9% a year. The last twelve months were down -30.2%. Price only, before dividends.

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
33.85%promoter holding, as of 2026-09-30-10.3 pts since 2021
Promoter share since listing
2021-0233.85% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
33.9%
63.3%
Promoter33.9%Foreign (FII)2.9%Public & others63.3%
Who is buying, who is leavingJun 25 to Sep 26
Promoter33.9%-0.7 pts
Foreign (FII)2.9%+1.3 pts
Domestic (DII)
-

Each line is that holder's share of all shares over the last 7 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Promoter pledgeThe share of promoters' holdings given to lenders as security for a loan.0.00%of promoter shares, as at 2026-09-30

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Copy of Newspaper Publication04-Nov-2026

JHS Svendgaard Laboratories Limited has informed the Exchange about Copy of Newspaper Publication for the Quarter and Half Year ended 30th September, 2026

Appointment02-Nov-2026

JHS Svendgaard Laboratories Limited has informed the Exchange regarding Appointment of Mr Pardeep Kumar Bhardwaj as Non- Executive Independent Director of the company w.e.f. November 02, 2026.

Outcome of Board Meeting02-Nov-2026

JHS Svendgaard Laboratories Limited has submitted to the Exchange, Un-audited-financial results for the period ended September 30, 2026.

Certificate under SEBI (Depositories and Participants) Regulations, 201809-Oct-2026

JHS Svendgaard Laboratories Limited has informed the Exchange about Certificate under Regulation 74(5) SEBI (Depositories and Participants) Regulations, 2018

Shareholders meeting29-Sep-2026

JHS Svendgaard Laboratories Limited has submitted the Exchange a copy Srutinizers report and voting results of Annual General Meeting held on September 26, 2026.

Shareholders meeting26-Sep-2026

JHS Svendgaard Laboratories Limited has informed the Exchange about the Proceedings of 22nd Annual General Meeting of the Company.

Trading Window21-Sep-2026

JHS Svendgaard Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

General Updates17-Sep-2026

JHS Svendgaard Laboratories Limited has informed the Exchange about letter sent to shareholders whose e-mail id not registerd

Copy of Newspaper Publication03-Sep-2026

JHS Svendgaard Laboratories Limited has informed the Exchange about Copy of Newspaper Publication regarding 22nd AGM Notice.

Shareholders meeting02-Sep-2026

JHS Svendgaard Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026

Copy of Newspaper Publication29-Aug-2026

JHS Svendgaard Laboratories Limited has informed the Exchange about Copy of Newspaper Publication of advertisement regarding the details of Annual General Meeting.

Copy of Newspaper Publication12-Aug-2026

JHS Svendgaard Laboratories Limited has informed the Exchange about Copy of Newspaper Publication regarding Un-Audited Financial Results for the Quarter Ended June 30, 2026.

Outcome of Board Meeting11-Aug-2026

JHS Svendgaard Laboratories Limited has submitted to the Exchange, the Un-Audited financial results for the period ended Jun 30, 2026.

Shareholders meeting31-Jul-2026

JHS Svendgaard Laboratories Limited has submitted the Exchange a copy Srutinizers report along with Voting Results of Postal Ballot concluded on 29 July 2026.

Shareholders meeting29-Jul-2026

JHS Svendgaard Laboratories Limited has informed the Exchange regarding Proceedings of Postal Ballot by Remote E-Voting Process by Members of the Company Concluded on July 29, 2026.

Backtest idea · JHSMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on JHS
Backtest idea · JHSLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on JHS
Backtest idea · JHSSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on JHS
Your own ideaWrite a rule for JHS in plain English“Buy JHS when …”
Start writing
Buy the dip on JHSBuy when RSI(14) drops below 30
52-week high breakout on JHSBuy when closes at a 52-week high
Golden cross on JHSBuy when 50-day EMA crosses above 200-day
Stochastic oversold on JHSBuy when stochastic %K drops below 20
Pullback in an uptrend on JHSBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹70 cr
Larger than 8% of 13 peers
sector middle ₹18,556 cr
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
0.4x
Lowest of 13 peers
sector middle 7.5x
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.
-1.1%
Lowest of 9 peers
sector middle 27.3%
FY23 -9.3%FY26 -1.1%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.
-0.8%
Lowest of 12 peers
sector middle 30.3%
FY23 -11.5%FY26 -0.8%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.08
Around the middle of 13 peers
sector middle 0.06
FY23 0.00FY26 0.08
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 54% of 13 peers
sector middle 0.6%
Sales growthHow much sales grew in the latest quarter against the same quarter a year earlier.
-2.0%
Lowest of 11 peers
sector middle +25.5%
FY23 11.5%FY26 10.5%

Peers are the listed companies in the exchange's own industry group: Personal Care. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Revenue and profit, year by yearSales and net profit by financial year or by quarter.

Sales and net profit
FY22FY23FY24FY25FY26
SalesNet profitfell vs last yearEach on its own scale · hover a bar for its figures
Op. marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.0.8%FY26SalesMoney earned from selling the company's goods and services, before any costs. Also called revenue.₹102 CrFY26Net profitWhat is left for shareholders after all costs, interest and tax.₹-2 CrFY26

Where every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.

FY26

In FY26, of every ₹100 of sales it kept ₹0.0 as profit. Other income added ₹3.3.

Where it wentPer ₹100 of sales
Running costs₹99.2Depreciation₹5.5Interest₹0.9
Profit per ₹100, year by year
FY22FY26

How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.

Compounded a year
3 years5 yearsLatest qtr
Sales+1.9%-▼ 2.0%
Profit---
3 and 5 years are compounded a year across full financial years. The latest quarter is against the same quarter a year earlier.

Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.

Where the cash went

In FY26 cash fell by ₹3 Cr, after ₹13 Cr spent on plant and equipment.

FY26Cash in or out
Running the business-₹3 Cr
Investing-₹12 Cr
Lenders and shareholders+₹11 Cr
Net change in cash-₹3 Cr

Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.

MeasureFY23FY24FY25FY26
Sales growthSales in this financial year against the previous one.11.5%-23.2%24.5%10.5%
Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.-8.9%-2.4%-6.5%0.8%
Net marginOf every ₹100 of sales in the year, how much was left as profit after everything.-17.5%-6.1%-21.4%-1.9%
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.-9.3%-2.6%-11.5%-1.1%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.-11.5%-1.7%-6.8%-0.8%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.00x0.02x0.03x0.08x
Interest coverHow many times the company's profit before interest could pay its interest bill.-13.5x-5.5x-19.8x-1.6x

Each row against this company's own usual level: green better, red worse, grey close to it.

Backtest idea · JHSStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on JHS
Backtest idea · JHSPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on JHS
Backtest idea · JHSBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on JHS
Backtest idea · JHS52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on JHS
Backtest idea · JHSGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on JHS
MACD momentum on JHSBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on JHSBuy when closes below the lower Bollinger band
Supertrend rider on JHSBuy when supertrend turns up
Buy the dip on JHSBuy when RSI(14) drops below 30
52-week high breakout on JHSBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Personal Care
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
GODREJCP
Godrej Consumer Products Limited
95,116 cr48.1x7.5x15.1%17.9%0.3711.9%+15.4%2.15%
DABUR
Dabur India Limited
69,300 cr34.2x6.0x16.2%20.7%0.1014.4%+11.7%2.30%
CUPID
Cupid Limited
49,208 cr290.4x87.4x27.3%33.9%0.1930.5%+122.5%0.00%
COLPAL
Colgate Palmolive (India) Limited
48,321 cr35.5x29.9x81.6%110.1%0.0021.3%+12.3%2.70%
GILLETTE
Gillette India Limited
23,310 cr34.1x21.7x69.1%94.3%0.0021.3%+4.3%4.19%
PGHH
Procter & Gamble Hygiene and Health Care Limited
22,469 cr28.9x25.4x113.7%156.1%0.0018.3%-0.4%3.68%
EMAMILTD
Emami Limited
18,556 cr24.9x6.3x27.6%29.7%0.0617.8%+36.2%2.59%
HONASA
Honasa Consumer Limited
17,268 cr61.0x11.6x15.4%20.9%0.0010.3%+35.9%0.57%
BAJAJCON
Bajaj Consumer Care Limited
5,321 cr21.5x5.9x25.3%31.0%0.0019.2%+25.5%0.00%
ANONDITA
Anondita Medicare Limited
1,978 cr44.1x8.2x-31.0%0.2941.6%+35.9%0.00%
MACOBSTECH
Macobs Technologies Limited
186 cr44.5x5.5x-13.4%0.227.3%-0.00%
AAKAAR
Aakaar Medical Technologies Limited
94 cr8.5x1.6x-15.0%0.3312.8%+72.7%0.00%
JHS
JHS Svendgaard Laboratories Limited
70 cr-0.4x-1.1%-0.8%0.08-1.1%-2.0%0.00%
MEDISTEP
Medistep Healthcare Limited
27 cr-0.8x--0.02--0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
+6.7
-9.3
-31.1
+35.1
+2.0
-17.4
+1.5
+6.5
+54.5
-35.8
+0.1
·
-18.5%
11m
2025
-6.0
-34.1
-14.5
+22.6
-3.9
+1.0
-5.0
-14.8
+0.7
+19.8
-17.5
-8.4
-53.5%
2024
+42.6
-33.5
-33.1
+15.8
+7.8
+5.3
+8.6
+24.3
+0.7
-11.8
-13.7
-3.7
-17.0%
2023
-11.6
-14.7
-8.0
+14.2
-4.2
+38.0
-11.1
+16.6
-3.5
+0.7
+15.3
-1.0
+20.3%
2022
+0.9
-18.6
-9.1
+36.0
-14.1
-10.4
+0.0
+5.1
+1.8
-5.0
+9.6
-6.7
-18.7%
2021
+11.8
-7.1
-20.0
+0.3
+3.5
+8.7
+15.5
-4.2
-2.6
+0.8
-6.7
+20.4
+14.3%
2020
-11.9
-18.4
-30.7
+33.1
-3.0
+96.4
-33.2
+39.1
+27.3
-20.1
+16.0
+14.5
+58.7%
2019
-19.9
-5.8
+7.1
-11.7
-4.9
-6.0
-14.6
-22.7
+13.8
+5.2
-3.2
-9.6
-55.9%
2018
-6.8
-4.4
-19.8
+22.5
-29.6
-12.7
+0.1
-23.1
-5.8
-9.7
+3.8
+25.1
-54.2%
2017
+5.9
-3.9
+1.6
+33.4
+9.5
+25.2
-7.2
+9.2
-10.8
+21.1
-5.8
+4.0
+102.3%
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2026-10-01BHIM SAIN BASSI · bulkSELL5,05,128₹12.74₹0.64 Cr
2025-09-04NIMISHA KHANDU SOLANKI · bulkBUY5,93,100₹12.00₹0.71 Cr
2025-09-04GREEN PORTFOLIO PRIVATE LIMITED · bulkSELL5,37,363₹11.62₹0.62 Cr
2024-09-04ASPIRE EMERGING FUND · bulkSELL15,00,000₹28.13₹4.22 Cr
2024-09-04AEGIS INVESTMENT FUND · bulkBUY14,31,000₹28.13₹4.03 Cr
2024-08-23SIXTH SENSE INDIA OPPORTUNITIES 11 · bulkSELL5,51,400₹24.93₹1.37 Cr
2024-08-08SIXTH SENSE INDIA OPPORTUNITIES 11 · bulkSELL5,00,000₹24.44₹1.22 Cr
2024-08-07SIXTH SENSE INDIA OPPORTUNITIES 11 · bulkSELL11,40,000₹22.22₹2.53 Cr

The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.

Read enough? Test JHS. “Buy JHS when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free